Noticias de LLY_US
Noticias del mercado
Últimas noticias sobre LLY_US — 1346 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
lily new weight loss drug
An investor who put $10,000 into Eli Lilly (LLY) stock on October 14, 2025 held about $15,500 by October 15, 2026. Placing that same sum in the S&P 500 over the identical period would have yielded about $11,790. By mid-2026, two drugs, Zepbound and Mounjaro, accounted for most of the company
Un inversor que invirtió 10.000 dólares en acciones de Eli Lilly (LLY) el 14 de octubre de 2025 tenía alrededor de 15.500 dólares el 15 de octubre de 2026. Colocar esa misma suma en el S&P 500 durante el mismo período habría generado alrededor de 11.790 dólares. A mediados de 2026, dos medicamentos, Zepbound y Mounjaro, representaban la mayor parte de la empresa.
Lilly bought 875,000 IPO shares at $14 each and agreed to a 180-day lock-up after October 8, 2026, subject to exceptions and underwriter consent.
Eli Lilly and Company (NYSE:LLY) has become one of the pharmaceutical industry’s most important growth stories, but its valuation presents a harder question than whether demand for obesity treatments will continue to rise. Investors must decide how much of that growth remains ahead, and how much is already reflected in the share price. Lilly’s shares […]
The Science Of Foundayo: How Eli Lilly's Daily Weight Loss Pill Works
Página 7 de 68